Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.

Articles Tagged with Risperdal Lawsuit

Risperdal LawsuitThe latest and largest Risperdal jury award is the fifth instance where juries found that the makers of Risperdal did not provide adequate warning of Risperdal’s risks to patients and doctors.

A Philadelphia jury awarded Andrew Yount $70 million after he suffered from Risperdal side effects. The Tennessee boy started taking Risperdal in 2003 when he was just five years old and developed gynecomastia (male breast growth) just one year after taking the anti-psychotic medication.

During the trial, it was the boy’s father testimony that convinced the jury that the giant drug company intentionally falsified, concealed or destroyed evidence. Attorneys’ representing Yount argued that Janssen, the manufacturer of Risperdal, knew about the link between Risperdal and gynecomastia yet decided to withhold that information. Yount’s attorneys provided Janssen’s internal documents that showed it purposely limited the medical community’s understanding of the risks associated with Risperdal.

Risperdal-Male-Breast-Growth-LawsuitMedical studies and recent lawsuits against the makers of Risperdal have helped highlight the links between the drug and gynecomastia, a condition that causes males to grow breasts.

A 2006 study conducted by Duke University showed that Risperdal was associated with gynecomastia and that it may cause lactation in girls, boys, and women not pregnant or nursing.

Despite this knowledge, the FDA approved Risperdal for the treatment of schizophrenia in children and bipolar disorder in both children and adults in 2007. The year after the FDA approval, the Wall Street Journal reported that Risperdal had been shown to increase prolactin levels (leading to breast development and lactation) and experts stated that up to 70 percent of gynecomastia childhood events were found to be caused by Risperdal use.

Risperdal-Male-Breast-Growth-LawsuitRisperdal is an effective drug for treatment of various degrees of psychosis and schizophrenia, ADHD and bipolar disorder. However, like other pharmaceuticals, there are Risperdal side effects, some of which can be particularly harmful to the elderly and children.
Last year the makers of Risperdal settled for $15.5 million a lawsuit filed by the Attorney General for the State of Kentucky. The lawsuit accused the makers of Risperdal of not disclosing risks associated with the drug to consumers, and marketing Risperdal for uses other than originally intended or approved for by the U.S. Food and Drug Administration (FDA). This has caused excessive and unnecessary costs to Medicaid and Medicare in the state, according to the lawsuit.
Among the allegations brought by the state of Kentucky was that the makers of Risperdal marketed the drug as an appropriate treatment for dementia in non-schizophrenic elderly patients. It was alleged that a study undertaken by the drug company had suggested death rates among the elderly in association with Risperdal use doubled the risk of death. And yet, not only did the makers of Risperdal market and promote the drug for use among the elderly for a use not approved by the FDA, they created an elder care sales force to further target the elderly market, according to the lawsuit.

Risperdal LawsuitMedical studies and recent lawsuits against the makers of Risperdal have helped highlight the links between the drug and gynecomastia, a condition that causes males to grow breasts.

A 2006 study conducted by Duke University showed that Risperdal was associated with gynecomastia and that it may cause lactation in girls, boys, and women not pregnant or nursing.

Despite this knowledge, the FDA approved Risperdal for the treatment of schizophrenia in children and bipolar disorder in both children and adults in 2007. The year after the FDA approval, the Wall Street Journal reported that Risperdal had been shown to increase prolactin levels (leading to breast development and lactation) and experts stated that up to 70 percent of gynecomastia childhood events were found to be caused by Risperdal use.

Risperdal-Male-Breast-Growth-LawsuitRisperdal is atypical antipsychotic that changes the effect of brain chemicals. The U.S. Department of Justice said that the makers of Risperdal illegally marketed drug to children. According to a former Johnson and Johnson sales manager, the company didn’t wait to obtain FDA approval before promoting its use for children.

During a Risperdal trial in Pennsylvania, a Johnson and Johnson sales manager admitted that the company trained salespeople to promote Risperdal to children as early as 2003. This was despite the fact that the drug was not approved for use by children.

This has led to a growing number of lawsuits against the company by several men who took the drug when they were children and developed male breasts, a condition known as Gynecomastia. Over the past few years, juries have awarded $2.5 million, $1.75 million, and $500,000 in cases filed in a Pennsylvania state court. Several other cases are expected to move forward in the next few months.

Risperdal lawsuit settlementsIf you file a Risperdal lawsuit, there is guarantee that you will win a trial verdict or obtain a settlement. But based on previous cases, it appears that the makers of Risperdal may be motivated to settle claims in order to avoid revealing information that may lead to more lawsuits or avoid trial verdicts.

Aron Banks was the first person to take his Risperdal personal injury claim to trail against the drug manufacturer. Banks was prescribed Risperdal when he was nine years old even though the drug wasn’t approved for use by children at the time. He experienced rapid weight gain, suffered injury to his endocrine system and experienced psychological trauma. He also developed breasts large enough to require surgery to remove them, a condition known as Gynecomastia.

In September 2012, the makers of Risperdal decided agreed to settle Banks case under the condition that neither Banks nor his attorney would reveal the amount. But his attorney did tell the media that he believed “the possibility of more evidence of off-label marketing and improper conduct by Johnson & Johnson had something to do with the settlement.”

Multiple lawsuits have been filed in the United States against the makers of Risperdal for failing to warn patients that it may cause male breast growth, a condition known as Gynecomastia.

Risperdal Male Breast Growth Lawsuit

Risperdal lawsuits increase in U.S.

Risperdal was approved for sale in the United States in 1993 by the Food and Drug Administration (FDA). It commonly used to treat irritability in people with autism, schizophrenia, and bipolar disorder.

Contact Information